gefitinib has been researched along with novobiocin in 5 studies
Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (novobiocin) | Trials (novobiocin) | Recent Studies (post-2010) (novobiocin) |
---|---|---|---|---|---|
5,231 | 566 | 2,919 | 2,271 | 15 | 290 |
Protein | Taxonomy | gefitinib (IC50) | novobiocin (IC50) |
---|---|---|---|
DNA gyrase subunit B | Mycolicibacterium smegmatis MC2 155 | 0.046 | |
DNA gyrase subunit B | Staphylococcus aureus | 0.0474 | |
DNA gyrase subunit B | Streptococcus pneumoniae TIGR4 | 0.037 | |
DNA gyrase subunit A | Escherichia coli K-12 | 0.1441 | |
DNA gyrase subunit B | Escherichia coli K-12 | 0.1537 | |
DNA topoisomerase 4 subunit B | Staphylococcus aureus | 7.9 | |
DNA gyrase subunit B | Mycolicibacterium smegmatis | 0.161 | |
DNA gyrase subunit A | Staphylococcus aureus | 0.0383 | |
DNA gyrase subunit B | Mycobacterium tuberculosis H37Rv | 0.0446 | |
DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | 0.1315 | |
DNA topoisomerase | Streptococcus pneumoniae | 2.03 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Müller, H; Pick, A; Wiese, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
1 review(s) available for gefitinib and novobiocin
Article | Year |
---|---|
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
4 other study(ies) available for gefitinib and novobiocin
Article | Year |
---|---|
Novel lead for potent inhibitors of breast cancer resistance protein (BCRP).
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Benzimidazoles; Cell Line, Tumor; Chlorophyll; Humans; Molecular Conformation; Neoplasm Proteins; Phenylurea Compounds; Small Molecule Libraries | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |